Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Teriparatide reported to reduce back pain in postmenopausal osteoporosis

May 6, 2004

European pivotal phase III trial for rhC1INH commences

May 6, 2004

New orexin antagonists for obesity and sleep disorders claimed by GSK

May 5, 2004

Novel estrogen receptor modulators under study at Merck

May 5, 2004

ThPTH successfully tested in first-in-man study

May 5, 2004

Preliminary results from Oralin clinical study

May 5, 2004

Phase I trial evaluates intranasal PTH1-34

May 5, 2004

Interim results for first phase III trial of AERx iDMS

May 4, 2004

NDA submission for Glumetza

May 4, 2004

Biovitrum licenses project in metabolic diseases

May 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Biotle’s FcRn inhibitor BTL-203 cleared for clinic in China
BioWorld Science
Biotle has received a clinical trial notice from China’s National Medical Products Administration (NMPA) for its IND application for BTL-203, the company’s...